Related Experiment Video
Updated: May 22, 2026
06:15
Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Primary intrapulmonary thymoma associated with myasthenia gravis
Meral Günaldi1, I Oguz Kara, Berna Bozkurt Duman
1Department of Medical Oncology, Cukurova University Faculty of Medicine, Saricam, Adana 01330, Turkey. meralgunaldi@gmail.com
General Thoracic and Cardiovascular Surgery
|May 22, 2012
Summary
Primary intrapulmonary thymoma, a rare lung tumor, can be associated with myasthenia gravis. This case highlights the severe, rapid progression of the disease, leading to a fatal outcome despite treatment attempts.
Area of Science:
- Oncology
- Pulmonology
- Neurology
Background:
- Primary intrapulmonary thymoma is an exceptionally rare neoplasm.
- Fewer than 31 cases have been documented globally.
- Co-occurrence with myasthenia gravis is exceedingly uncommon.
Observation:
- A 58-year-old male presented with a right lower lobe lung mass.
- Histological analysis confirmed a Type AB thymoma.
- Post-operative respiratory distress led to intubation and positive acetylcholine receptor antibody tests.
Findings:
- The patient was diagnosed with myasthenia gravis.
- Despite planned treatment (pyridostigmine, plasmapheresis), therapy could not commence.
- Rapid respiratory decline and subsequent intubation-associated pneumonia proved fatal.
Implications:
- This case underscores the critical and potentially rapid progression of intrapulmonary thymoma associated with myasthenia gravis.
- It highlights the challenges in managing such rare and aggressive presentations.
- Emphasizes the need for prompt recognition and aggressive management strategies for this rare condition.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...